A Cost Benefit Analysis of AminoIndex Cancer Screening in Japan


This article presents a cost benefit analysis of AminoIndex Cancer Screening (AICS) in Japan. AICS is a new cancer diagnosis method based on profiles of amino acids. The cost benefit analysis is performed on each type of cancer, each sex, and each age class. The results indicate that AICS is cost-beneficial mainly for 50-75 years old for screening of several types of cancer including stomach, lung, and colorectal cancer. AICS is also cost-beneficial for younger female for screening of uterine-ovarian cancer.21 p

Similar works

This paper was published in HERMES-IR.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.